Two observational studies indicate GLP-1 receptor agonists may reduce complications after transcatheter aortic valve replacement (TAVR) and carotid artery stenting (CAS). Post-TAVR tirzepatide use was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results